Solaris Vaccines, Inc. — Form D
Solaris Vaccines, Inc. of FORT COLLINS, CO, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-07. The offering totals $500K, of which $500K was reported sold. Industry: Other.
Offering
- Filed: 2022-01-07
- Form: D
- Accession: 0001903363-22-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $500K
- Investors: 1
- Date of first sale: 2021-12-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-428364
Issuer
- Name: Solaris Vaccines, Inc.
- CIK: 0001903363
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 320 E. VINE DRIVE, FORT COLLINS, CO, 80524
- Phone: 4795712592
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Robert Calvin Goforth | Director | Fayetteville, AR |
| Michael Calvin Artinger | Director | Fort Collins, CO |
| Michael Calvin Artinger | Executive Officer | Fort Collins, CO |
Other filings by this issuer (1)
More